|Disease Group:||Leukemia; Lymphoma; Myeloma|
|Phase of Study:||Phase II|
|Treatment Agents:||Cord Blood Transplantation|
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||100 days post transplant, and will include inpatient and out patient care |
during this time period.
|Return Visit:||Every 3 months during the first year as feasible.|
|Home Care:||IV fluids, etc. as determined by patient's clinical status.|